Cargando…

APEX1 promotes the oncogenicity of hepatocellular carcinoma via regulation of MAP2K6

Objective: Apurinic/apyrimidinic endonuclease 1 (APEX1), a key enzyme responsible for DNA base excision repair, has been linked to development and progression of cancers. In this work, we aimed to explore the role of APEX1 in hepatocellular carcinoma (HCC) and elucidate its molecular mechanism. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Zhipeng, Chen, Guangyang, Wang, Liang, Sang, Qing, Xu, Guangzhong, Zhang, Nengwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596212/ https://www.ncbi.nlm.nih.gov/pubmed/36205565 http://dx.doi.org/10.18632/aging.204325

Ejemplares similares

Identification of APEX2 as an oncogene in liver cancer
por: Zheng, Ru, et al.
Publicado: (2020)

Transcriptomic analysis reveals the oncogenic role of S6K1 in hepatocellular carcinoma
por: Lai, Keng Po, et al.
Publicado: (2020)

Cost-Effectiveness of Bariatric Surgery for Type 2 Diabetes Mellitus: A Randomized Controlled Trial in China
por: Tang, Qi, et al.
Publicado: (2016)

APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Cao, Lei, et al.
Publicado: (2020)

The oncogene Mct-1 promotes progression of hepatocellular carcinoma via enhancement of Yap-mediated cell proliferation
por: Yang, Wenjie, et al.
Publicado: (2021)

NOL12 as an Oncogenic Biomarker Promotes Hepatocellular Carcinoma Growth and Metastasis
por: Huang, Jianfeng, et al.
Publicado: (2022)

Long-Term Weight Loss Outcome of Laparoscopic Sleeve Gastrectomy Predicted by the Percentage of Excess Weight Loss at 6 Months in Chinese Patients with Body Mass Index ≥ 32.5 Kg/m(2)
por: Wang, Liang, et al.
Publicado: (2022)

Screening Driving Transcription Factors in the Processing of Gastric Cancer
por: Xu, Guangzhong, et al.
Publicado: (2016)

PHF8 Plays an Oncogene Function in Hepatocellular Carcinoma Formation
por: Ye, Hong, et al.
Publicado: (2019)

SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
por: Yang, Yu-Feng, et al.
Publicado: (2018)

Carcinoma of the Apex of the Lung with Horner's Syndrome
por: Gharpure, P. V.
Publicado: (1945)

Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways
por: Lu, Haofeng, et al.
Publicado: (2022)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

The MAP3K7-mTOR Axis Promotes the Proliferation and Malignancy of Hepatocellular Carcinoma Cells
por: Cheng, Jin-Shiung, et al.
Publicado: (2019)

Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
por: Sun, Zhipeng, et al.
Publicado: (2014)

Comparison Between the Accuracy of NovApex Apex Locator and Radiographs in Determining Radiographic Apex
por: Shahi, Shahriar, et al.
Publicado: (2011)

Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma
por: Yu, Shian, et al.
Publicado: (2023)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022)

Integrative Genomics Identifies YY1AP1 as an Oncogenic Driver in EpCAM(+) AFP(+) Hepatocellular Carcinoma
por: Zhao, Xuelian, et al.
Publicado: (2015)

CD146, from a melanoma cell adhesion molecule to a signaling receptor
por: Wang, Zhaoqing, et al.
Publicado: (2020)

Integrin-Linked Kinase Overexpression and Its Oncogenic Role in Promoting Tumorigenicity of Hepatocellular Carcinoma
por: Chan, Jenny, et al.
Publicado: (2011)

Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma
por: Zhang, Min, et al.
Publicado: (2015)

CircUBAP2 Promotes MMP9-Mediated Oncogenic Effect via Sponging miR-194-3p in Hepatocellular Carcinoma
por: Liu, Boqiang, et al.
Publicado: (2021)

SMG9 Serves as an Oncogene to Promote the Tumor Progression via EMT and Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma
por: Jin, Xing, et al.
Publicado: (2021)

The Y-linked proto-oncogene TSPY contributes to poor prognosis of the male hepatocellular carcinoma patients by promoting the pro-oncogenic and suppressing the anti-oncogenic gene expression
por: Kido, Tatsuo, et al.
Publicado: (2019)

LLGL2 Increases Ca(2+) Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma
por: Leng, Shusheng, et al.
Publicado: (2021)

Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma
por: Shen, J, et al.
Publicado: (2016)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma
por: Song, Huijuan, et al.
Publicado: (2020)

ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
por: Ni, Sheng, et al.
Publicado: (2020)

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022)

Mapping of Membrane Lipid Order in Root Apex Zones of Arabidopsis thaliana
por: Zhao, Xiaoyu, et al.
Publicado: (2015)

An APEX2 proximity ligation method for mapping interactions with the nuclear lamina
por: Tran, Joseph R., et al.
Publicado: (2020)

MYB proto-oncogene like 2 promotes hepatocellular carcinoma growth and glycolysis via binding to the Optic atrophy 3 promoter and activating its expression
por: Liu, Miao, et al.
Publicado: (2022)

Endogenous Retrotransposition Activates Oncogenic Pathways in Hepatocellular Carcinoma
por: Shukla, Ruchi, et al.
Publicado: (2013)

The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
por: Puigvehí, Marc, et al.
Publicado: (2019)

Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma
por: Wu, Zhixian, et al.
Publicado: (2022)

The Student at the Apex
Publicado: (1893)

CD147 reinforces [Ca(2+)](i) oscillations and promotes oncogenic progression in hepatocellular carcinoma
por: Tang, Juan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_epkgi5uar3sdq9lrupeeeeh1oq